Literature DB >> 30940520

NF-κB pathway and the Goldilocks principle: Lessons from human disorders of immunity and inflammation.

Ori Scott1, Chaim M Roifman2.   

Abstract

Nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling pathways play a key role in various cell processes related to host immunity. The last few years have seen an explosion of disorders associated with NF-κB components from core members of the canonical and noncanonical cascades to adaptor protein and ubiquitination-related enzymes. Disease phenotypes have extended beyond susceptibility to infections and include autoimmunity, lymphoproliferation, atopy, and inflammation. Concurrently, studies are unveiling a tightly regulated system marked by extensive cross-talk between the canonical and noncanonical pathways, as well as among the NF-κB and other signaling pathways. As the rate of discovery in the realm of NF-κB defects accelerates, this review presents a timely summary of major known defects causing human disease, as well as diagnostic, therapeutic, and research challenges and opportunities.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NF-κB; canonical; immune regulation; noncanonical; signaling

Year:  2019        PMID: 30940520     DOI: 10.1016/j.jaci.2019.03.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Redox Homeostasis in Poultry: Regulatory Roles of NF-κB.

Authors:  Peter F Surai; Ivan I Kochish; Michael T Kidd
Journal:  Antioxidants (Basel)       Date:  2021-01-28

Review 2.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

3.  Primary immunodeficiency-related genes in neonatal intensive care unit patients with various genetic immune abnormalities: a multicentre study in China.

Authors:  Tianwen Zhu; Xiaohui Gong; Fei Bei; Li Ma; Jingjing Sun; Jian Wang; Gang Qiu; Jianhua Sun; Yu Sun; Yongjun Zhang
Journal:  Clin Transl Immunology       Date:  2021-03-22

4.  Case Report: Post-Partum Complications of NFκB1 Deficiency Underscore a Need to Better Understand Primary Immunodeficiency Management During Pregnancy.

Authors:  Diem-Tran I Nguyen; Amanda Grimes; Donald Mahoney; Sebastian Faro; William T Shearer; Aaron L Miller; Nicholas L Rider
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

5.  Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway.

Authors:  Rui Zhang; Nan Guo; Genquan Yan; Qian Wang; Tiantian Gao; Baoke Zhang; Ning Hou
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

6.  RNA-seq profiles of chicken type II pneumocyte in response to Escherichia coli infection.

Authors:  Lu-Yuan Peng; Zhen-Qiang Cui; Zong-Mei Wu; Ben-Dong Fu; Peng-Fei Yi; Hai-Qing Shen
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

Review 7.  Type I interferons and endoplasmic reticulum stress in health and disease.

Authors:  Jenny Sprooten; Abhishek D Garg
Journal:  Int Rev Cell Mol Biol       Date:  2019-11-19       Impact factor: 6.813

Review 8.  Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity.

Authors:  Jessica D Gereige; Paul J Maglione
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

Review 9.  Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.

Authors:  Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robyn E O'Hehir; Menno C van Zelm
Journal:  Cell Mol Immunol       Date:  2020-08-17       Impact factor: 11.530

Review 10.  Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis.

Authors:  Meng-Ge Yang; Li Sun; Jinming Han; Chao Zheng; Hudong Liang; Jie Zhu; Tao Jin
Journal:  Mol Brain       Date:  2019-12-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.